These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 25458169)
1. Early diagnosis of Danon disease: Flow cytometric detection of lysosome-associated membrane protein-2-negative leukocytes. Hashida Y; Wada T; Saito T; Ohta K; Kasahara Y; Yachie A J Cardiol; 2015 Aug; 66(2):168-74. PubMed ID: 25458169 [TBL] [Abstract][Full Text] [Related]
2. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Fanin M; Nascimbeni AC; Fulizio L; Spinazzi M; Melacini P; Angelini C Am J Pathol; 2006 Apr; 168(4):1309-20. PubMed ID: 16565504 [TBL] [Abstract][Full Text] [Related]
3. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency. Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987 [TBL] [Abstract][Full Text] [Related]
4. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Dougu N; Joho S; Shan L; Shida T; Matsuki A; Uese K; Hirono K; Ichida F; Tanaka K; Nishino I; Inoue H Circ J; 2009 Feb; 73(2):376-80. PubMed ID: 19057086 [TBL] [Abstract][Full Text] [Related]
5. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing. Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667 [TBL] [Abstract][Full Text] [Related]
6. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene. Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725 [TBL] [Abstract][Full Text] [Related]
7. Danon disease: case report and detection of new mutation. Regelsberger G; Höftberger R; Pickl WF; Zlabinger GJ; Körmöczi U; Salzer-Muhar U; Luckner D; Bodamer OA; Mayr JA; Muss WH; Budka H; Bernheimer H J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S115-22. PubMed ID: 19588270 [TBL] [Abstract][Full Text] [Related]
8. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease. Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report. Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794 [TBL] [Abstract][Full Text] [Related]
10. Identification of Two Novel LAMP2 Gene Mutations in Danon Disease. Csányi B; Popoiu A; Hategan L; Hegedűs Z; Nagy V; Rácz K; Hőgye M; Sághy L; Iványi B; Csanády M; Forster T; Sepp R Can J Cardiol; 2016 Nov; 32(11):1355.e23-1355.e30. PubMed ID: 27179547 [TBL] [Abstract][Full Text] [Related]
12. A new phenotype of severe dilated cardiomyopathy associated with a mutation in the LAMP2 gene previously known to cause hypertrophic cardiomyopathy in the context of Danon disease. Gourzi P; Pantou MP; Gkouziouta A; Kaklamanis L; Tsiapras D; Zygouri C; Constantoulakis P; Adamopoulos S; Degiannis D Eur J Med Genet; 2019 Jan; 62(1):77-80. PubMed ID: 29753918 [TBL] [Abstract][Full Text] [Related]
14. [Danon disease: a case report and literature overview]. Catović S; Otasević P Srp Arh Celok Lek; 2007; 135(3-4):197-200. PubMed ID: 17642461 [TBL] [Abstract][Full Text] [Related]
15. Paediatric hypertrophic cardiomyopathy secondary to Danon disease. Tang K; Wu J; Liu X; Wang S Cardiol Young; 2024 Jan; 34(1):201-204. PubMed ID: 37990583 [TBL] [Abstract][Full Text] [Related]
16. Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics. Majer F; Pelak O; Kalina T; Vlaskova H; Dvorakova L; Honzik T; Palecek T; Kuchynka P; Masek M; Zeman J; Elleder M; Sikora J J Inherit Metab Dis; 2014 Jan; 37(1):117-24. PubMed ID: 23716275 [TBL] [Abstract][Full Text] [Related]
17. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease. Türkmen H; Uysal F; Bostan ÖM Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912 [TBL] [Abstract][Full Text] [Related]
18. A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy. Yu L; Wan K; Han Y; Chen Y Eur Heart J; 2018 Sep; 39(34):3263-3264. PubMed ID: 29240871 [No Abstract] [Full Text] [Related]
19. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy. Xu J; Wang L; Liu X; Dai Q Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081 [TBL] [Abstract][Full Text] [Related]
20. Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study. Gurka J; Piherova L; Majer F; Chaloupka A; Zakova D; Pelak O; Krebsova A; Peichl P; Krejci J; Freiberger T; Melenovsky V; Kautzner J; Kalina T; Sikora J; Kubanek M ESC Heart Fail; 2020 Oct; 7(5):2534-2543. PubMed ID: 32657043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]